USP7 and cancer: USP7 is known to be occasionally overexpressed in several cancers, and this overexpression has been reported to be closely associated with the chemoresistance of tumors to anticancer chemical drugs and increased metastatic ability, resulting in poor clinical outcomes in patients with cancer [2,3,4].